Source:http://linkedlifedata.com/resource/pubmed/id/19185318
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2009-3-3
|
pubmed:abstractText |
We report on a 27-year-old man with Fabry disease who had widespread white-matter lesions (WMLs) despite the absence of renal or cardiac manifestations. Genomic analysis revealed a novel mutation: a GAT deletion at nucleotide position 234-236 in exon 5 of the coding region. After 12 months of enzyme replacement therapy (ERT), most of the WMLs had disappeared. Cell counts and protein levels in the cerebrospinal fluid also decreased. These findings suggest that ERT may play a role in the recovery of WMLs.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1878-5883
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
279
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
118-20
|
pubmed:meshHeading |
pubmed-meshheading:19185318-Adult,
pubmed-meshheading:19185318-Brain,
pubmed-meshheading:19185318-Fabry Disease,
pubmed-meshheading:19185318-Humans,
pubmed-meshheading:19185318-Magnetic Resonance Imaging,
pubmed-meshheading:19185318-Male,
pubmed-meshheading:19185318-Nerve Fibers, Myelinated,
pubmed-meshheading:19185318-Sequence Deletion,
pubmed-meshheading:19185318-Treatment Outcome,
pubmed-meshheading:19185318-alpha-Galactosidase
|
pubmed:year |
2009
|
pubmed:articleTitle |
Amelioration of white-matter lesions in a patient with Fabry disease.
|
pubmed:affiliation |
Department of Neurology D4, Osaka University Graduate School of Medicine, Osaka, Japan. misaky@neurol.med.osaka-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Case Reports
|